Cell
Volume 149, Issue 2, 13 April 2012, Pages 274-293
Journal home page for Cell

Review
mTOR Signaling in Growth Control and Disease

https://doi.org/10.1016/j.cell.2012.03.017Get rights and content
Under an Elsevier user license
open archive

The mechanistic target of rapamycin (mTOR) signaling pathway senses and integrates a variety of environmental cues to regulate organismal growth and homeostasis. The pathway regulates many major cellular processes and is implicated in an increasing number of pathological conditions, including cancer, obesity, type 2 diabetes, and neurodegeneration. Here, we review recent advances in our understanding of the mTOR pathway and its role in health, disease, and aging. We further discuss pharmacological approaches to treat human pathologies linked to mTOR deregulation.

Cited by (0)

4

Present address: Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Faculté de Médecine, Université Laval, 2725 Chemin Ste-Foy, Québec, QC G1V 4G5, Canada